{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:31:58Z","timestamp":1767990718778,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00192-024-05819-y","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T13:01:45Z","timestamp":1716814905000},"page":"1581-1584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Microbiologist in the Clinic: Postmenopausal Woman with Chronic OAB and Positive Urine Culture"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-2589","authenticated-orcid":false,"given":"Linda","family":"Brubaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Horsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajvinder","family":"Khasriya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan J.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"issue":"10","key":"5819_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nri3887","volume":"15","author":"SN Abraham","year":"2015","unstructured":"Abraham SN, Miao Y. The nature of immune responses to urinary tract infections. Nat Rev Immunol. 2015;15(10):655\u201363. https:\/\/doi.org\/10.1038\/nri3887.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"5819_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jinf.2008.12.009","volume":"58","author":"ME Falagas","year":"2009","unstructured":"Falagas ME, Kotsantis IK, Vouloumanou EK, Rafailidis PI. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect. 2009;58(2):91\u2013102. https:\/\/doi.org\/10.1016\/j.jinf.2008.12.009.","journal-title":"J Infect"},{"issue":"4","key":"5819_CR3","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1099\/jmm.0.068783-0","volume":"63","author":"KL Nielsen","year":"2014","unstructured":"Nielsen KL, Dynesen P, Larsen P, Frimodt-M\u00f8ller N. Faecal Escherichia coli from patients with E. coli urinary tract infection and healthy controls who have never had a urinary tract infection. J Med Microbiol. 2014;63(4):582\u20139. https:\/\/doi.org\/10.1099\/jmm.0.068783-0.","journal-title":"J Med Microbiol"},{"key":"5819_CR4","doi-asserted-by":"publisher","unstructured":"Hayes BW, Abraham SN. Innate immune responses to bladder infection. Microbiol Spectr. 2016;4(6). https:\/\/doi.org\/10.1128\/microbiolspec.uti-0024-2016.","DOI":"10.1128\/microbiolspec.uti-0024-2016"},{"issue":"35","key":"5819_CR5","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1016\/j.vaccine.2019.07.031","volume":"37","author":"CA Sarkissian Milner","year":"2019","unstructured":"Sarkissian Milner CA, Alteri CJ, Mobley HLT. UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens. Vaccine. 2019;37(35):4937\u201346. https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.031.","journal-title":"Vaccine"},{"issue":"6","key":"5819_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41590-020-0688-3","volume":"21","author":"J Wu","year":"2020","unstructured":"Wu J, Hayes BW, Phoenix C, et al. A highly polarized TH2 bladder response to infection promotes epithelial repair at the expense of preventing new infections. Nat Immunol. 2020;21(6):671\u201383. https:\/\/doi.org\/10.1038\/s41590-020-0688-3.","journal-title":"Nat Immunol"},{"issue":"1","key":"5819_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mucimm.2022.12.003","volume":"16","author":"CCY Chieng","year":"2023","unstructured":"Chieng CCY, Kong Q, Liou NSY, Khasriya R, Horsley H. The clinical implications of bacterial pathogenesis and mucosal immunity in chronic urinary tract infection. Mucosal Immunol. 2023;16(1):61\u201371. https:\/\/doi.org\/10.1016\/j.mucimm.2022.12.003.","journal-title":"Mucosal Immunol"},{"issue":"4","key":"5819_CR8","doi-asserted-by":"publisher","first-page":"164971","DOI":"10.1128\/msystems.01371-20","volume":"6","author":"L Brubaker","year":"2021","unstructured":"Brubaker L. Forming consensus to advance urobiome research. mSystems. 2021;6(4):164971.","journal-title":"mSystems"},{"issue":"6","key":"5819_CR9","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.euf.2022.05.006","volume":"8","author":"V Antoniou","year":"2022","unstructured":"Antoniou V, Somani BK. Topical and oral oestrogen for recurrent urinary tract infection\u2014evidence-based review of literature, treatment recommendations, and correlation with the European Association of Urology guidelines on urological infections. Eur Urol Focus. 2022;8(6):1768\u201374.","journal-title":"Eur Urol Focus"},{"key":"5819_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fruro.2023.1206046","author":"L Brubaker","year":"2023","unstructured":"Brubaker L, Chai T, Horsley H, Khasriya R, Moreland RB, Wolfe AJ. Tarnished gold\u2013the \u201cstandard\u201d urine culture: reassessing the characteristics of a criterion standard for detecting urinary microbes. Front Urol. 2023. https:\/\/doi.org\/10.3389\/fruro.2023.1206046.","journal-title":"Front Urol"},{"issue":"23","key":"5819_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/QOIZ6538","volume":"26","author":"C Harding","year":"2022","unstructured":"Harding C, Chadwick T, Homer T, Ali A. Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT. Health Technol Assess. 2022;26(23):1\u2013172.","journal-title":"Health Technol Assess"},{"issue":"2","key":"5819_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3892\/ijo.2018.4661","volume":"54","author":"V Schirrmacher","year":"2019","unstructured":"Schirrmacher V. From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment (review). Int J Oncol. 2019;54(2):407\u201319. https:\/\/doi.org\/10.3892\/ijo.2018.4661.","journal-title":"Int J Oncol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-024-05819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-024-05819-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-024-05819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T02:01:50Z","timestamp":1725760910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-024-05819-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["5819"],"URL":"https:\/\/doi.org\/10.1007\/s00192-024-05819-y","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]},"assertion":[{"value":"22 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As no protected health information was included in this conversational commentary, no ethical approval was sought or required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"L.B.: editorial stipends from JAMA and Up To Date; H.H.: no disclosures; H.K.: no disclosures; A.J.W.: advisory boards at Urobiome Therapeutics and Pathnostics and funding from NIH, Craig H. Neilsen Foundation, Pathnostics, and VB Tech.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}